Transcat, Inc. distributes test and measurement instruments and provides accredited calibration services to a variety of industries including life sciences, pharmaceutical, petroleum refining, chemical manufacturing, public utility, pulp and paper, communications, automotive and aerospace.
Revenue (Most Recent Fiscal Year) | $230.57M |
Net Income (Most Recent Fiscal Year) | $10.69M |
PE Ratio (Current Year Earnings Estimate) | 60.83 |
PE Ratio (Trailing 12 Months) | 72.82 |
PEG Ratio (Long Term Growth Estimate) | -- |
Price to Sales Ratio (Trailing 12 Months) | 4.23 |
Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 4.86 |
Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | 41.98 |
Pre-Tax Margin (Trailing 12 Months) | 5.45% |
Net Margin (Trailing 12 Months) | 4.16% |
Return on Equity (Trailing 12 Months) | 9.32% |
Return on Assets (Trailing 12 Months) | 5.69% |
Current Ratio (Most Recent Fiscal Quarter) | 3.37 |
Quick Ratio (Most Recent Fiscal Quarter) | 2.81 |
Debt to Common Equity (Most Recent Fiscal Quarter) | 0.01 |
Inventory Turnover (Trailing 12 Months) | 10.74 |
Book Value per Share (Most Recent Fiscal Quarter) | $13.18 |
Earnings per Share (Most Recent Fiscal Quarter) | $0.38 |
Earnings per Share (Most Recent Fiscal Year) | $1.40 |
Diluted Earnings per Share (Trailing 12 Months) | $1.30 |
Exchange | NASDAQ |
Sector | Industrials |
Industry | Industrial Distribution |
Common Shares Outstanding | 8.83M |
Free Float | 8.46M |
Market Capitalization | $1.06B |
Average Volume (Last 20 Days) | 0.04M |
Beta (Past 60 Months) | 0.61 |
Percentage Held By Insiders (Latest Annual Proxy Report) | 4.20% |
Percentage Held By Institutions (Latest 13F Reports) | 98.34% |
Annual Dividend (Based on Last Quarter) | $0.00 |
Dividend Yield (Based on Last Quarter) | 0.00% |